Kythera net loss worsens in Q3

• Kythera Biopharmaceuticals (NASDAQ:KYTH -3.4%) Q3 results: Revenue: $0; Operating Loss: ($21.3M) (-93.6%); Net Loss: ($22.5M) (-95.7%); Loss Per Share: ($0.99) (-59.7%); Quick Assets: $117.4M (-31.8%).
• No guidance given.